Patient#	Sample#	PKC zeta/Par6/CDC42/GTP:(PKC zeta/Par3/Par6/CDC42/GTP, active),	positive regulation of NF-kappaB transcription factor activity:(RhoA/GTP, active),	ACTA1:(ACTA1, protein),(Actin/MAL, active),	CDKN1B:(CDKN1B, protein),(RhoA/GTP, active),	CIT:(CIT, protein),(RhoA/GTP, active),	Citron:(Citron, protein),(RhoA/GTP, active),	Dia:(Dia, protein),(RhoA/GTP, active),	MKK3-MKK6:(MKK3-MKK6, protein),	PKN:(PKN, protein),(RhoA/GTP, active),	PKN2:(PKN2, protein),(RhoA/GTP, active),	PLD2:(PLD2, protein),(RhoA/GTP, active),	ROCK1-ROCK2:(ROCK1-ROCK2, protein),(RhoA/GTP, active),	TLN1:(TLN1, protein),	ERM family:(ERM family, protein),(ROCK1-ROCK2, active),	Golgi organization:(CIT, active),	LIMK1-LIMK2:(LIMK1-LIMK2, protein),(ROCK1-ROCK2, active),	MAP2K4:(MAP2K4, protein),(ROCK1-ROCK2, active),	MKK3-MKK6-active:(MKK3-MKK6, active),(MKK3-MKK6-active, protein),(PKN, active),	MYL2:(Citron, active),(MYL2, protein),	PI5K Type 1 family:(PI5K Type 1 family, protein),(ROCK1-ROCK2, active),	PTEN:(PTEN, protein),(ROCK1-ROCK2, active),	SH3GL2:(ROCK1-ROCK2, active),(SH3GL2, protein),	SLC9A3:(ROCK1-ROCK2, active),(SLC9A3, protein),	actin cytoskeleton organization:(PKN2, active),	degradation:(CDKN1B, active),	myosin phosphatase complex:(ROCK1-ROCK2, active),	CFL1:(CFL1, protein),(LIMK1-LIMK2, active),	F2RL2:(F2RL2, protein),(PKC zeta/Par3/Par6/CDC42/GTP, active),(ROCK1-ROCK2, active),	MAPK12:(MAPK12, protein),(MKK3-MKK6-active, active),	MAPK8:(MAP2K4, active),(MAPK8, protein),	PI-4-5-P2:(PI-4-P, active),(PI5K Type 1 family, active),	SLC9A1:(ROCK1-ROCK2, active),(SLC9A1, protein),	myosin II complex:(ROCK1-ROCK2, active),(myosin phosphatase complex, active),	ATF2:(ATF2, protein),(MAPK12, active),(MAPK8, active),	MKL1:(Actin/MAL, active),(CFL1, active),(Dia, active),(MKL1, protein),	actin filament depolymerization:(CFL1, active),	stress fiber formation:(Dia, active),(myosin II complex, active),	MAL(dimer):(MKL1, active),	cell adhesion mediated by integrin:(SLC9A1, active),	SRF(dimer)/MAL(dimer):(MAL(dimer), active),(SRF(dimer), active),	CYR61:(CYR61, protein),	FOS:(FOS, protein),	SRF:(SRF, protein),	VCL:(VCL, protein),	Vinculin/Talin:(PI-4-5-P2, active),(TLN1, active),(VCL, active),	focal adhesion formation:(ERM family, active),(Vinculin/Talin, active),	ATF2/JUN	JUN:(JUN, protein),(MAPK8, active),	
